Date: 28.8.2020
With the aim of reducing rates of the mosquito-borne illnesses yellow fever and dengue, a pilot program will release 750 million genetically modified mosquitoes into the Florida Keys in 2021, thanks to approval by the barrier islands’ Mosquito Control District Board of Commissioners at a meeting on Tuesday (August 18).
The strain of GM mosquitoes, known as OX513A, is an altered form of Aedes aegypti created by UK-based biotech firm Oxitec. Released mosquitoes will be all male, as male mosquitoes do not bite and generally only feed on nectar. Thanks to a conditionally lethal genetic variant, when OX513A mosquitoes mate with wild females, their offspring should die before they are old enough for females to begin biting.
Over the last 10 years, Oxitec deployed these GM mosquitoes in the Cayman Islands and Brazil. This will be the first release of any GM mosquitoes in the US. The Centers for Disease Control and Prevention (CDC) and scientists at the University of Florida will oversee program.
“It’s gone extremely well,” Oxitec scientist Kevin Gorman tells the AP. “We have released over a billion of our mosquitoes over the years. There is no potential for risk to the environment or humans.”
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology links - Useful biotech links for you
Biotechnology - Biotech information at Wikipedia
Reduce, reuse, reflycle: How genetically modified flies can reduce waste and keep it out of landfills
3D laser printing with bioinks from microalgae